Latest Research Study On Surface Disinfectants Market
The Global Surface Disinfectants Market reached US$ 3.1 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 5.7 billion by 2031. The global Surface Disinfectants market is expected to exhibit a CAGR of 8.1% during the forecast period 2024-2031.
Surface Disinfectants are chemical solutions designed to kill or inactivate harmful microorganisms, such as bacteria, viruses, and fungi, on surfaces. These products are commonly used in households, healthcare settings, and public spaces to prevent the spread of infections and maintain cleanliness. Surface disinfectants work by disrupting the cell structure of pathogens, effectively rendering them harmless.
Surface disinfectants are essential for maintaining hygiene and safety in various environments, especially where cleanliness is critical, like hospitals, kitchens, and schools. These disinfectants come in many forms, including sprays, wipes, and liquids, and are designed to be easy to apply and highly effective. With the rising awareness of health and safety, especially post-pandemic, the demand for reliable disinfecting products has surged. Manufacturers continue to innovate with formulas that not only kill harmful germs but also cater to eco-friendly and non-toxic preferences, ensuring that users can maintain a clean and safe environment without compromising on health or sustainability.
Download Free Sample PDF: https://www.datamintelligence.com/download-sample/surface-disinfectant-market
Market Growth Drivers:
Increasing Incidence of Hospital-Acquired Infections Fueling the Growth of the Surface Disinfectants Market
The rising number of hospital-acquired infections is expected to drive significant growth in the global surface disinfectants market during the forecast period. For example, the U.S. Department of Health and Human Services reports that 1 in 31 hospitalized patients has at least one hospital-associated infection at any given time, resulting in over 680,000 infections and billions of dollars in additional healthcare costs each year in the United States alone.
Many of these infections are caused by antibiotic-resistant pathogens, which are increasingly difficult to treat. In addition, hospital-associated infections can lead to sepsis, a serious condition that affects approximately 1.7 million people and causes over 270,000 deaths annually in the U.S.
The Presence of Strict Regulatory Authorities is Expected to Restrain the Growth of the Global Surface Disinfectants Market During the Forecast Period.
The strict regulations surrounding the approval of new surface disinfectants are expected to hinder the global market’s growth during the forecast period. For example, disinfectant registration is governed by the Central Drugs Standard Control Organisation (CDSCO) under the Drug and Cosmetics Act. All relevant drug regulations must be followed for disinfectants to be listed, adding complexity to the approval process.
Market Segments:
- By Product: Quaternary Ammonium Compounds, Peracetic Acid, Hydrogen Peroxide, Phenol, Alcohol, Sodium Hypochlorite, Hypochlorite, Others.
- By Formulation: Wipes, Sprays, Liquids.
- By End-User: Hospitals & Clinics, Outpatient Surgical Centres, Restaurants & Food Chains, Households, Others.
- By Region: North America, Latin America, Europe, Asia Pacific, Middle East and Africa
Top Key Players:
- Procter & Gamble
- Reckitt Benckiser Group plc.
- Carroll Company
- Cantel Medical Corporation
- UPS Hygiene Pvt. Ltd.
- Metrex Research, LLC.
- STERIS plc.
- Whiteley Corporation
- PURE Bioscience, Inc.
- Henkel AG
Customize Your Scope: https://www.datamintelligence.com/customize/surface-disinfectant-market
Regional Growth
By 2031, North America is expected to account for around 38.2% of the market share, driven by the rise in hospital-associated infections.
Due to the rising cases of hospital-associated infections, North America is projected to hold the largest share of the global surface disinfectants market during the forecast period. For example, the Centers for Disease Control and Prevention (CDC) estimates that in U.S. hospitals and clinics, HAIs lead to around 1.7 million infections and over 99,000 related deaths each year. Among these, 32% are urinary tract infections, over 22% are surgical site infections, about 15% are pneumonia (lung infections), and around 14% are bloodstream infections.
Key Development
In March 2022, PDI launched a range of innovative disinfectant products, including the Sani-24 Germicidal Disposable Wipe, Sani-HyPerCide Germicidal Disposable Wipe, and Sani-HyPerCide Germicidal Spray. These products are designed to support infection prevention professionals in combating the increasing incidence of healthcare-associated infections (HAIs).
